U-I medical administrator sees hope in development of COVID-19 vaccine


The University of Iowa’s Vice President for Medical Affairs, Brooks Jackson, says he is encouraged about the prospect for a COVID-19 vaccine.

“The data emerging on the leading COVID-19 vaccine candidates currently in large phase-three clinical trials in the U.S. looks very promising,” Jackson says. Jackson says Iowa is doing its part.  The U-I is one of the sites in the Pfizer COVID-19 trial and he says they recently completed the target enrollment for the trial.